epibatidine and n-(1-methylethyl)-1,1,2-trimethylpropylamine

epibatidine has been researched along with n-(1-methylethyl)-1,1,2-trimethylpropylamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hu, G; Hu, J; Lindenberger, K; Lukas, RJ; Wang, H; Wu, J	1

Other Studies

1 other study(ies) available for epibatidine and n-(1-methylethyl)-1,1,2-trimethylpropylamine

Article	Year
Iptakalim as a human nicotinic acetylcholine receptor antagonist. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 316, Issue:2 Topics: Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Cloning, Molecular; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Ion Channel Gating; Nicotinic Agonists; Nicotinic Antagonists; Patch-Clamp Techniques; Propylamines; Pyridines; Receptors, Nicotinic; Time Factors	2006

Article

Year

Iptakalim as a human nicotinic acetylcholine receptor antagonist.

The Journal of pharmacology and experimental therapeutics, 2006, Volume: 316, Issue:2

Topics: Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Cloning, Molecular; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Ion Channel Gating; Nicotinic Agonists; Nicotinic Antagonists; Patch-Clamp Techniques; Propylamines; Pyridines; Receptors, Nicotinic; Time Factors

2006